| Osteoporosis, Postmenopausal
Climara Pro vs Miacalcin
Side-by-side clinical, coverage, and cost comparison for osteoporosis, postmenopausal.Deep comparison between: Climara Pro vs Miacalcin with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsMiacalcin has a higher rate of injection site reactions vs Climara Pro based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Miacalcin but not Climara Pro, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Climara Pro
Miacalcin
At A Glance
Transdermal patch
Weekly
Estrogen/progestogen combination
SC or IM injection
Daily to every 6 hours
Calcitonin receptor agonist
Indications
- Menopausal syndrome
- Osteoporosis, Postmenopausal
- Osteitis Deformans
- Hypercalcemia
- Osteoporosis, Postmenopausal
Dosing
Menopausal syndrome, Osteoporosis, Postmenopausal 0.045 mg estradiol/0.015 mg levonorgestrel per day applied transdermally once weekly; for vasomotor symptoms, attempts to discontinue should be made at 3 to 6 month intervals.
Osteitis Deformans 100 USP Units (0.5 mL) once daily by subcutaneous or intramuscular injection; ensure adequate calcium and vitamin D intake.
Hypercalcemia Start at 4 USP Units/kg every 12 hours SC or IM; increase to 8 USP Units/kg every 12 hours if no response in 1-2 days; may further increase to 8 USP Units/kg every 6 hours if no response after 2 more days.
Osteoporosis, Postmenopausal 100 USP Units (0.5 mL) once daily by subcutaneous or intramuscular injection; ensure adequate calcium (at least 1000 mg/day) and vitamin D (at least 400 IU/day) supplementation.
Contraindications
- Undiagnosed abnormal genital bleeding
- Breast cancer or history of breast cancer
- Estrogen-dependent neoplasia
- Active DVT, PE, or a history of these conditions
- Active arterial thromboembolic disease (e.g., stroke or MI), or a history of these conditions
- Known anaphylactic reaction, angioedema, or hypersensitivity to Climara Pro
- Hepatic impairment or disease
- Protein C, protein S, or antithrombin deficiency, or other thrombophilic disorders
- Hypersensitivity to calcitonin salmon or any of the excipients (reactions have included anaphylaxis with death, bronchospasm, and swelling of the tongue or throat)
Adverse Reactions
Most common (>3%) Application site reaction, vaginal bleeding, breast pain, upper respiratory infection, back pain, depression, headache, pain, flu syndrome, abdominal pain, arthralgia, edema, flatulence, hypertension, bronchitis, sinusitis, urinary tract infection
Serious Cardiovascular disorders, malignant neoplasms
Postmarketing Changes in bleeding patterns, abdominal distension, abdominal pain, nausea, alopecia, night sweats, pruritus, rash, hot flush, dizziness, headache, insomnia, application site reaction, weight increased, anaphylactic reaction
Most common (>=10%) Nausea with or without vomiting, local inflammatory reactions at injection site
Most common (2-5%) Flushing of face or hands, skin rashes, pruritus of the ear lobes
Serious Hypersensitivity reactions including anaphylaxis, hypocalcemia with tetany and seizures, malignancy (increased incidence observed in meta-analysis)
Postmarketing Bronchospasm, urticaria, influenza-like symptoms, fatigue, edema, arthralgia, musculoskeletal pain, hypertension, abdominal pain, diarrhea, polyuria, dizziness, headache, paresthesia, tremor, visual disturbance
Pharmacology
Estrogen/progestogen combination; estradiol binds nuclear estrogen receptors in estrogen-responsive tissues to reduce elevated postmenopausal gonadotropin levels, while levonorgestrel inhibits gonadotropin production and counteracts the proliferative effects of estrogen on the endometrium.
Calcitonin receptor agonist; calcitonin salmon acts primarily on bone to produce a marked transient inhibition of osteoclast-mediated bone resorption, with additional direct effects on the kidneys increasing excretion of phosphate, calcium, and sodium, and actions on the gastrointestinal tract.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Climara Pro
- Covered on 5 commercial plans
- PA (4/12) · Step Therapy (0/12) · Qty limit (9/12)
Miacalcin
- Covered on 5 commercial plans
- PA (5/12) · Step Therapy (0/12) · Qty limit (0/12)
UnitedHealthcare
Climara Pro
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (6/8)
Miacalcin
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
Humana
Climara Pro
- Covered on 0 commercial plans
- PA (1/3) · Step Therapy (0/3) · Qty limit (2/3)
Miacalcin
- Covered on 0 commercial plans
- PA (1/3) · Step Therapy (0/3) · Qty limit (0/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Climara Pro.
Cost estimate not availableAssistance Fund: Hypophosphatasia (HPP)
Commercial or private insurance
Medicare, Medicaid, VA, TRICARE
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
Climara ProView full Climara Pro profile
MiacalcinView full Miacalcin profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.